contact us to

get started

Contact Sales

Model N BPI Gross to Net

Home / Model N BPI Gross to Net

Model N BPI Gross to Net

Drive higher net revenue and reduce risk associated with gross-to-net forecasting, accrual management and reporting.

Make better-informed decisions with complete gross-to-net visibility

Fast and complete visibility into pre-deal and “what if” analysis, the true price of products, true net revenue, accurate accruals, full audit reporting, and reliable forecasts is critical to pharmaceutical and medical technology manufacturers. The stakes are high—in 2017, manufacturers of brand-name drugs reduced list price revenues by $153 billion, twice what it was only 5 years ago. To drive top line growth, manufacturers make faster, smarter, better-informed business decisions with the Model N BPI Gross to Net solution, combining Model N’s trusted revenue execution platform with BPI Technologies’ advanced analytics tools.


Model N BPI Gross to Net unites Model N’s trusted transaction data sets with BPI Technologies’ gross-to-net revenue recognition tools, enabling manufacturers to achieve complete gross-to-net visibility in near-real-time at every step of the revenue lifecycle. The combined solution will feature:

  • No touch integration from Model N to BPI
  • Comprehensive structural and transactional data across commercial, government, and chargeback channels
  • Sophisticated gross-to-net revenue recognition
  • Deployment flexibility: cloud, on-premise, both
  • Availability targeted for Winter 2019
abstract computer graphics business financial statistics currency


Though just one component of commercial strategy, Model N BPI Gross to Net will provide customers the ability to make better-informed business decisions. Customers can expect to achieve maximum growth and increased profitability, among other benefits:

  • Understand true price of products and net revenue
  • Visibility into pre-deal and price impact “what if” analysis
  • Trusted accrual forecasts and reconciliation of revenues and discounts
  • Reduce risk in gross to net with accurate reserves
  • Improve operational efficiency
digital tablet with finance chart

The Power of Model N BPI Gross to Net for the pharmaceutical industry

Combined with the entire Model N Revenue Execution Cloud for Pharma suite, manufacturers are able to streamline and automate the entire revenue management process throughout the organization. From sales and marketing, finance and contracting, to legal and regulatory, the Revenue Cloud for Pharma suite is the most comprehensive solution available.

Featured Resources
Recent Posts

Start typing and press Enter to search